These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 19915944)
1. Raised concentration of soluble form of vascular endothelial cadherin and IL-23 in sera of patients with Behçet's disease. Habibagahi Z; Habibagahi M; Heidari M Mod Rheumatol; 2010 Apr; 20(2):154-9. PubMed ID: 19915944 [TBL] [Abstract][Full Text] [Related]
2. Increased serum soluble vascular endothelial cadherin levels in patients with chronic spontaneous urticaria. Chen T; Guo ZP; Wang WJ; Fu LX; Sun QM; Zhou PM Ann Allergy Asthma Immunol; 2017 Jun; 118(6):704-709. PubMed ID: 28583263 [TBL] [Abstract][Full Text] [Related]
3. Increased serum levels of soluble vascular endothelial-cadherin in patients with systemic vasculitis. Chen T; Guo ZP; Cao N; Qin S; Li MM; Jia RZ Rheumatol Int; 2014 Aug; 34(8):1139-43. PubMed ID: 24469639 [TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial cadherin shedding is more severe in sepsis patients with severe acute kidney injury. Yu WK; McNeil JB; Wickersham NE; Shaver CM; Bastarache JA; Ware LB Crit Care; 2019 Jan; 23(1):18. PubMed ID: 30658667 [TBL] [Abstract][Full Text] [Related]
5. Soluble Vascular Endothelial Cadherin as a New Biomarker of Irradiation in Highly Irradiated Baboons with Bone Marrow Protection. Hérodin F; Voir D; Vilgrain I; Courçon M; Drouet M; Boittin FX Health Phys; 2016 Jun; 110(6):598-605. PubMed ID: 27115227 [TBL] [Abstract][Full Text] [Related]
6. sVE-cadherin and sCD146 serum levels in patients with multiple myeloma. Wrobel T; Mazur G; Wolowiec D; Jazwiec B; Sowinska E; Kuliczkowski K Clin Lab Haematol; 2006 Feb; 28(1):36-9. PubMed ID: 16430458 [TBL] [Abstract][Full Text] [Related]
7. Soluble vascular endothelial-cadherin levels correlate with clinical and biological aspects of severe ovarian hyperstimulation syndrome. Villasante A; Pacheco A; Pau E; Ruiz A; Pellicer A; Garcia-Velasco JA Hum Reprod; 2008 Mar; 23(3):662-7. PubMed ID: 18216038 [TBL] [Abstract][Full Text] [Related]
8. Correlation between IL-17A/F, IL-23, IL-35 and IL-12/-23 (p40) levels in peripheral blood lymphocyte cultures and disease activity in Behcet's patients. Sonmez C; Yucel AA; Yesil TH; Kucuk H; Sezgin B; Mercan R; Yucel AE; Demirel GY Clin Rheumatol; 2018 Oct; 37(10):2797-2804. PubMed ID: 29557072 [TBL] [Abstract][Full Text] [Related]
9. Investigating the role of IL-33 in the pathogenesis of Behçet's Disease. Çerçi P; Altıner S; İnal A; Köse K; Keskin G; Ölmez Ü Acta Clin Belg; 2017 Dec; 72(6):434-438. PubMed ID: 28412856 [TBL] [Abstract][Full Text] [Related]
10. Levels of soluble E-selectin in patients with active Behcet's disease. Sari RA; Kiziltunç A; Taysi S; Akdemir S; Gündoğdu M Clin Rheumatol; 2005 Feb; 24(1):55-9. PubMed ID: 15338451 [TBL] [Abstract][Full Text] [Related]
11. Serum angiostatin levels in patients with Behçet's disease: does angiogenesis play a role in the pathogenesis of Behçet's disease? Keskin D; Keskin G; Inal A; Ozışık L Acta Clin Belg; 2014 Aug; 69(4):246-50. PubMed ID: 25012748 [TBL] [Abstract][Full Text] [Related]
12. Soluble vascular endothelial-cadherin levels in patients with sepsis treated with direct hemoperfusion with a polymyxin B-immobilized fiber column. Ebihara I; Hirayama K; Nagai M; Koda M; Gunji M; Okubo Y; Katayama T; Sato C; Usui J; Yamagata K; Kobayashi M Ther Apher Dial; 2014 Jun; 18(3):272-8. PubMed ID: 24965294 [TBL] [Abstract][Full Text] [Related]
13. Plasma sE-cadherin and the plasma sE-cadherin/sVE-cadherin ratio are potential biomarkers for chronic obstructive pulmonary disease. Shirahata T; Nakamura H; Nakajima T; Nakamura M; Chubachi S; Yoshida S; Tsuduki K; Mashimo S; Takahashi S; Minematsu N; Tateno H; Asano K; Fujishima S; Betsuyaku T Biomarkers; 2018 Jul; 23(5):414-421. PubMed ID: 29376431 [TBL] [Abstract][Full Text] [Related]
14. The relationship of serum VEGF and sVEGFR-1 levels with vascular involvement in patients with Behçet's disease. Sertoglu E; Omma A; Yucel C; Colak S; Sandıkcı SC; Ozgurtas T Scand J Clin Lab Invest; 2018 Oct; 78(6):443-449. PubMed ID: 30015524 [TBL] [Abstract][Full Text] [Related]
15. Increased expression of interleukin-23 p19 mRNA in erythema nodosum-like lesions of Behçet's disease. Lew W; Chang JY; Jung JY; Bang D Br J Dermatol; 2008 Mar; 158(3):505-11. PubMed ID: 18205865 [TBL] [Abstract][Full Text] [Related]
16. Increased serum levels of interleukin-8 in polyarteritis nodosa and Behçet's disease. Freire Ade L; Bertolo MB; de Pinho AJ; Samara AM; Fernandes SR Clin Rheumatol; 2004 Jun; 23(3):203-5. PubMed ID: 15168145 [TBL] [Abstract][Full Text] [Related]
17. IL-38 serum levels in patients with Behcet's disease and the relationship with clinical features. Zarrabi M; Gholijani N; Shenavandeh S; Aflaki E; Amirghofran Z Eur Cytokine Netw; 2019 Sep; 30(3):82-87. PubMed ID: 31957702 [TBL] [Abstract][Full Text] [Related]
18. Immunometabolic biomarkers of inflammation in Behçet's disease: relationship with epidemiological profile, disease activity and therapeutic regimens. Cantarini L; Pucino V; Vitale A; Talarico R; Lucherini OM; Magnotti F; De Rosa V; Galgani M; Alviggi C; Marone G; Galeazzi M; Matarese G Clin Exp Immunol; 2016 May; 184(2):197-207. PubMed ID: 26756979 [TBL] [Abstract][Full Text] [Related]
19. Increased levels of soluble vascular endothelial cadherin are associated with poor outcome in severe sepsis. Zhang RY; Liu YY; Li L; Cui W; Zhao KJ; Huang WC; Gu XW; Liu W; Wu J; Min D; Mao EQ; Tang YQ J Int Med Res; 2010; 38(4):1497-506. PubMed ID: 20926024 [TBL] [Abstract][Full Text] [Related]
20. Serum galectin-3 levels in patients with Behçet's disease: association with disease activity over a long-term follow-up. Özden MG; Caycı YT; Tekin H; Çoban AY; Aydın F; Sentürk N; Bek Y; Cantürk T; Turanlı AY J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1168-73. PubMed ID: 21214630 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]